Research Paper Volume 16, Issue 19 pp 12769—12780
Bezafibrate mitigates cardiac injury against coronary microembolization by preventing activation of p38 MAPK/NF-κB signaling
Figure 3. Bezafibrate ameliorated oxidative stress in cardiac tissues of CME rats. (A) GPx levels; (B) SOD activity; (C) TBARS level; (D) NOX activity (n=12, **, p<0.01 vs. control group; #, ##, p<0.05, 0.01 vs. CME group).